SecSonar.com

Baxter International Inc. (BAX)

Baxter International Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Baxter International Inc. (BAX) is a Medical - Instruments & Supplies company based in US with a market capitalization of $9.8B. Revenue grew 5.7% year-over-year and the company generated $323M in free cash flow. This page tracks BAX's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 38K employees · IPO Oct 27, 1981

Valuation

Valuation & price

$17.30 · as of May 17, 2026 · -43.6% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

1.60

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$29.81$22.89$15.97Jul 25Dec 25Jul 26Jul 7, 25$29.69Jul 9, 25$29.81Jul 11, 25$28.70Jul 15, 25$28.25Jul 17, 25$27.89Jul 21, 25$27.37Jul 23, 25$28.56Jul 25, 25$29.22Jul 29, 25$28.84Jul 31, 25$21.76Aug 4, 25$22.44Aug 6, 25$22.50Aug 11, 25$23.46Aug 13, 25$24.11Aug 15, 25$24.18Aug 19, 25$24.33Aug 21, 25$23.85Aug 25, 25$24.56Aug 27, 25$24.53Aug 29, 25$24.69Sep 3, 25$23.54Sep 5, 25$24.42Sep 9, 25$24.45Sep 11, 25$24.49Sep 16, 25$23.87Sep 18, 25$23.69Sep 22, 25$22.81Sep 24, 25$22.56Sep 26, 25$21.98Sep 30, 25$22.77Oct 2, 25$23.23Oct 6, 25$23.15Oct 8, 25$22.75Oct 10, 25$21.95Oct 14, 25$22.82Oct 16, 25$22.97Oct 21, 25$22.75Oct 23, 25$22.99Oct 27, 25$23.17Oct 29, 25$22.42Oct 31, 25$18.47Nov 4, 25$17.94Nov 6, 25$17.98Nov 10, 25$17.75Nov 12, 25$18.70Nov 14, 25$18.47Nov 18, 25$18.15Nov 20, 25$17.42Nov 25, 25$18.66Nov 28, 25$18.74Dec 2, 25$18.84Dec 4, 25$18.48Dec 8, 25$18.16Dec 10, 25$18.26Dec 12, 25$19.15Dec 16, 25$19.05Dec 18, 25$19.07Dec 22, 25$18.98Dec 24, 25$19.11Dec 29, 25$19.25Jan 2, 26$19.50Jan 6, 26$20.55Jan 8, 26$20.69Jan 12, 26$20.15Jan 14, 26$19.84Jan 16, 26$20.11Jan 21, 26$19.71Jan 23, 26$19.84Jan 27, 26$19.57Jan 29, 26$19.73Feb 2, 26$19.87Feb 4, 26$21.03Feb 9, 26$21.73Feb 11, 26$22.28Feb 13, 26$19.79Feb 18, 26$21.87Feb 20, 26$21.58Feb 24, 26$20.63Feb 26, 26$20.36Mar 2, 26$19.69Mar 4, 26$19.03Mar 6, 26$17.69Mar 10, 26$17.46Mar 12, 26$18.01Mar 17, 26$17.62Mar 19, 26$16.66Mar 23, 26$16.61Mar 25, 26$17.12Mar 27, 26$15.97Mar 31, 26$16.80Apr 2, 26$16.68Apr 7, 26$16.62Apr 9, 26$17.30Apr 13, 26$17.63Apr 15, 26$17.60Apr 17, 26$18.71Apr 22, 26$18.31Apr 24, 26$18.16Apr 28, 26$17.94Apr 30, 26$17.58May 4, 26$16.62May 6, 26$16.98May 8, 26$17.99May 12, 26$17.89May 14, 26$17.78May 18, 26$17.79May 20, 26$18.77May 22, 26$19.18May 28, 26$19.25Jun 1, 26$18.40Jun 3, 26$18.54Jun 5, 26$19.38Jun 9, 26$20.03Jun 11, 26$20.49Jun 15, 26$20.81Jun 17, 26$19.39Jun 22, 26$19.66Jun 24, 26$21.04Jun 26, 26$22.04Jul 2, 26$22.68
$15.8052-week range$30.66
Loading valuation history…

Fundamentals

Key fundamentals

$9.8B

Market cap

5.7%

Revenue growth (YoY)

30.1%

Gross margin

$323M

Free cash flow (USD)

$8B

Net debt

0.6%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$10.2BFY 2017$10.6BFY 2018$11.1BFY 2019$11.4BFY 2020$11.7BFY 2021$12.1BFY 2022$10.1BFY 2023$10.4BFY 2024$10.6BFY 2025$11.2B
$10.2B$11.2B

Free cash flow by year

2016 → 2025

FY 2016$935.0MFY 2017$1.1BFY 2018$1.4BFY 2019$1.4BFY 2020$1.2BFY 2021$1.5BFY 2022$576.0MFY 2023$1.3BFY 2024$559.0MFY 2025$323.0M
$935M$323M

Gross margin by year

2021 → 2025

FY 202138.9%FY 202235.3%FY 202340.1%FY 202437.5%FY 202530.1%
38.9%30.1%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed Apr 30, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventExecutive Severance PlanMay 8, 2026Filing
  • 8-K eventEarnings ReleaseApr 30, 2026Filing
  • Quarterly report10-Q FiledApr 30, 2026Filing

Questions

Frequently asked questions

What is Baxter International Inc.'s market cap?

Baxter International Inc. (BAX) has a market capitalization of $9.8B.

What is BAX's P/E ratio?

A meaningful P/E ratio is not available for BAX — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is BAX's price-to-book (P/B) ratio?

BAX trades at 1.60 times book value per share.

Are insiders buying BAX stock?

SEC Form 4 filings show no open-market insider buys at Baxter International Inc. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Instruments & Supplies

COO

The Cooper Companies, Inc.

$12B

ATR

AptarGroup, Inc.

$7.4B

RGEN

Repligen Corporation

$7.1B

AVTR

Avantor, Inc.

$6.4B

TFX

Teleflex Incorporated

$5.7B

STVN

Stevanato Group S.p.A.

$5.2B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.